Pre-eclampsia is a major cause of maternal mortality (15–20% in developed countries) and
morbidities (acute and long-term), perinatal deaths, preterm birth, and intrauterine growth …

OBJECTIVE: We sought to review the risks and benefits of expectant management of severe
preeclampsia remote from term, and to provide recommendations for expectant …

Severe preeclampsia that develops at< 34 weeks of gestation is associated with high
perinatal mortality and morbidity rates. Management with immediate delivery leads to high …

Objective: The aim of the study was to determine the risk factors, prevalance,
epidemiological parameters and maternal-perinatal outcome in pregnant women with …

Hypertensive disorders of pregnancy are one of the leading causes of poor pregnancy
outcomes and are associated with increased rates of maternal mortality, preterm birth, small …

Objective The objective of the study was to determine whether expectant management of
severe preeclampsia prior to 34 weeks of gestation results in improved neonatal outcome in …

Objective: To compare outcomes associated with expectant vs. interventionist care of severe
preeclampsia in observational studies. Data Sources: Medline (01/1980–07/2007) …

OBJECTIVE: The objective was to compare the safety and efficacy of intravenous labetalol
and intravenous hydralazine for acutely lowering blood pressure in pregnancy. STUDY …

Objectives Plasma volume expansion may benefit both mother and child in the temporising
management of severe and early onset hypertensive disorders of pregnancy. Design …

Background: Hypertensive disorders during pregnancy occur in women with preexisting
primary or secondary chronic hypertension, and in women who develop new-onset …